- Home
- Publications
- Publication Search
- Publication Details
Title
Systems biology of cisplatin resistance: past, present and future
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 5, Pages e1257-e1257
Publisher
Springer Nature
Online
2014-05-30
DOI
10.1038/cddis.2013.428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: Molecular mechanisms unveiled by gene expression profiling
- (2013) Martin Koch et al. BIOCHEMICAL PHARMACOLOGY
- Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
- (2013) J Mendoza et al. BRITISH JOURNAL OF CANCER
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
- (2013) C. J. Huntoon et al. CANCER RESEARCH
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- Prognostic value of LIPC in non-small cell lung carcinoma
- (2013) Lorenzo Galluzzi et al. CELL CYCLE
- Vitamin B6 metabolism influences the intracellular accumulation of cisplatin
- (2013) Lorenzo Galluzzi et al. CELL CYCLE
- Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer
- (2013) Judith Michels et al. CELL CYCLE
- Crosstalk between ER stress and immunogenic cell death
- (2013) Oliver Kepp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells
- (2013) Fang Wang et al. FEBS LETTERS
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- ATP11B mediates platinum resistance in ovarian cancer
- (2013) Myrthala Moreno-Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
- (2013) Yong Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
- (2013) S. S. More et al. JOURNAL OF NEUROSCIENCE
- Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria
- (2013) Michaela Aichler et al. JOURNAL OF PATHOLOGY
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Integrated proteomic analysis of post-translational modifications by serial enrichment
- (2013) Philipp Mertins et al. NATURE METHODS
- ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
- (2013) Luc Friboulet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses
- (2013) L Galluzzi et al. ONCOGENE
- miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1
- (2013) Li Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds
- (2013) Takatoshi Karasawa et al. PLoS One
- The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
- (2013) Yong Yang et al. PLoS One
- MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction Chemoradiotherapy
- (2012) Michael Augustine Ko et al. ANNALS OF THORACIC SURGERY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents
- (2012) Ossama Sharaf el dein et al. BIOCHEMICAL PHARMACOLOGY
- Overexpression of IL-7 enhances cisplatin resistance in glioma
- (2012) Lei Cui et al. CANCER BIOLOGY & THERAPY
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- RhoJ Regulates Melanoma Chemoresistance by Suppressing Pathways That Sense DNA Damage
- (2012) H. Ho et al. CANCER RESEARCH
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Cisplatin Sensitivity Mediated by WEE1 and CHK1 Is Mediated by miR-155 and the miR-15 Family
- (2012) L. M. Pouliot et al. CANCER RESEARCH
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
- (2012) Angelina V. Vaseva et al. CELL
- Independent transcriptional reprogramming and apoptosis induction by cisplatin
- (2012) Lorenzo Galluzzi et al. CELL CYCLE
- Association of CASP7 Polymorphisms and Survival of Patients With Non-small Cell Lung Cancer With Platinum-Based Chemotherapy Treatment
- (2012) Ji Qian et al. CHEST
- Mitochondrial Control of Cellular Life, Stress, and Death
- (2012) Lorenzo Galluzzi et al. CIRCULATION RESEARCH
- Genome-Wide Association Study of Prognosis in Advanced Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2012) L. Hu et al. CLINICAL CANCER RESEARCH
- Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention
- (2012) M. A. T. Hildebrandt et al. CLINICAL CANCER RESEARCH
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2012) Sergio Marchini et al. EUROPEAN JOURNAL OF CANCER
- Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144
- (2012) Idoia G. Zubeldia et al. EXPERIMENTAL CELL RESEARCH
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- Mechanism of cisplatin resistance in human urothelial carcinoma cells
- (2012) Hui-Min Yu et al. FOOD AND CHEMICAL TOXICOLOGY
- Integrated epigenomics identifiesBMP4as a modulator of cisplatin sensitivity in gastric cancer
- (2012) Tatiana Ivanova et al. GUT
- Validated gene targets associated with curatively treated advanced serous ovarian carcinoma
- (2012) Joyce N. Barlin et al. GYNECOLOGIC ONCOLOGY
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- (2012) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
- (2012) Nicole P. Chappell et al. JOURNAL OF PROTEOME RESEARCH
- Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cells
- (2012) Vivekananda Shetty et al. Journal of Proteomics
- Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
- (2012) Céline Jacquemont et al. Molecular Cancer
- Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
- (2012) Siqing Fu et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma
- (2012) J. Keating et al. MOLECULAR CANCER THERAPEUTICS
- Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
- (2012) Z. D. Liang et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin treatment leads to changes in nuclear protein and microRNA expression
- (2012) Guanglin Zhang et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Minimizing the damage: repair pathways keep mitochondrial DNA intact
- (2012) Lawrence Kazak et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- DNA damage checkpoints in stem cells, ageing and cancer
- (2012) Tobias Sperka et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ethylene in vegetative development: a tale with a riddle
- (2012) Filip Vandenbussche et al. NEW PHYTOLOGIST
- PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations
- (2012) Z Yao et al. ONCOGENE
- RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance
- (2012) F Salm et al. ONCOGENE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Association Between CASP8 and CASP10 Polymorphisms and Toxicity Outcomes With Platinum-Based Chemotherapy in Chinese Patients With Non-Small Cell Lung Cancer
- (2012) J. Qian et al. ONCOLOGIST
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- A Head and Neck Cancer Tumor Response-Specific Gene Signature for Cisplatin, 5-Fluorouracil Induction Chemotherapy Fails with Added Taxanes
- (2012) Céline Tomkiewicz et al. PLoS One
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin
- (2012) L. C. Godoy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis of human DNA polymerase -mediated chemoresistance to cisplatin
- (2012) Y. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
- (2012) Dianke Yu et al. TUMOR BIOLOGY
- Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
- (2012) Lorenzo Galluzzi et al. Cell Reports
- Loss-of-function alleles ofP2RX7andTLR4fail to affect the response to chemotherapy in non-small cell lung cancer
- (2012) Erika Vacchelli et al. OncoImmunology
- Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275
- (2011) Annette Bangert et al. ANTI-CANCER DRUGS
- Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast
- (2011) Laura Gatti et al. BMC GENOMICS
- miRNA signature associated with outcome of gastric cancer patients following chemotherapy
- (2011) Chang Hee Kim et al. BMC Medical Genomics
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
- (2011) Jeanine M.L. Roodhart et al. CANCER CELL
- An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells
- (2011) Chantal Garand et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non-Small Cell Lung Cancer Treated with Chemotherapy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2011) X.-L. Tan et al. CLINICAL CANCER RESEARCH
- BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
- (2011) D. C. Marchion et al. CLINICAL CANCER RESEARCH
- p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins
- (2011) Huimei Yu et al. EUROPEAN JOURNAL OF CANCER
- Impact of cisplatin administration on protein expression levels in renal cell carcinoma: A proteomic analysis
- (2011) Radovan Vasko et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
- (2011) Qi Wang et al. EXPERIMENTAL LUNG RESEARCH
- The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
- (2011) Hye Sook Chon et al. GYNECOLOGIC ONCOLOGY
- Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer
- (2011) Hua-Zong Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer
- (2011) Jian Cheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease
- (2011) Hans Zischka et al. JOURNAL OF CLINICAL INVESTIGATION
- A new high resolution screening method for study of phenotype stress responses of Saccharomyces cerevisae mutants
- (2011) Håvard Sletta et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2011) Xifeng Wu et al. JNCI-Journal of the National Cancer Institute
- Systems biology of kidney diseases
- (2011) John Cijiang He et al. KIDNEY INTERNATIONAL
- Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
- (2011) Helen H.W. Chen et al. LUNG CANCER
- miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
- (2011) Wei Zhu et al. MEDICAL ONCOLOGY
- PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria–nucleus signalling
- (2011) Aleck W.E. Jones et al. MITOCHONDRION
- A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110 Isoform in Medulloblastoma Cell Proliferation and Chemoresistance
- (2011) A. S. Guerreiro et al. MOLECULAR CANCER RESEARCH
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Large-scale phosphosite quantification in tissues by a spike-in SILAC method
- (2011) Mara Monetti et al. NATURE METHODS
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma
- (2011) T Jiffar et al. ONCOGENE
- MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
- (2011) L Sun et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- RAB8 Enhances TMEM205-Mediated Cisplatin Resistance
- (2011) Ding-Wu Shen et al. PHARMACEUTICAL RESEARCH
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
- (2011) H E Wheeler et al. PHARMACOGENOMICS JOURNAL
- A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
- (2011) Hark Kyun Kim et al. PLoS One
- Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa Cells
- (2011) Juan D. Chavez et al. PLoS One
- Genome-Wide Local Ancestry Approach Identifies Genes and Variants Associated with Chemotherapeutic Susceptibility in African Americans
- (2011) Heather E. Wheeler et al. PLoS One
- Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
- (2011) Wei Yu et al. PLoS One
- A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer
- (2011) Jialou Zhu et al. PLoS One
- Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents
- (2011) A. R. Goloudina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
- (2010) Su Wei Wong et al. BREAST CANCER RESEARCH AND TREATMENT
- A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin
- (2010) Ken André Olaussen CANCER BIOLOGY & THERAPY
- Acquired Cisplatin Resistance in Human Lung Adenocarcinoma Cells Is Associated with Enhanced Autophagy
- (2010) Jing-Hua Ren et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
- (2010) M. Tanioka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
- (2010) L. Galluzzi et al. CANCER RESEARCH
- Illicit survival of cancer cells during polyploidization and depolyploidization
- (2010) I Vitale et al. CELL DEATH AND DIFFERENTIATION
- MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
- (2010) et al. CLINICAL CANCER RESEARCH
- A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer
- (2010) Xi Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance
- (2010) Ding-Wu Shen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs
- (2010) Bernhard Michalke JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients
- (2010) Baohui Han et al. LUNG CANCER
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- Autophagy and the Integrated Stress Response
- (2010) Guido Kroemer et al. MOLECULAR CELL
- Mass spectrometry in high-throughput proteomics: ready for the big time
- (2010) Tommy Nilsson et al. NATURE METHODS
- Testicular germ cell tumors: pathogenesis, diagnosis and treatment
- (2010) Christian Winter et al. Nature Reviews Endocrinology
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species
- (2009) X. Deng et al. CANCER RESEARCH
- Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs
- (2009) Satoshi Mizutani et al. CANCER SCIENCE
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
- (2009) John R. Eckardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- The Translesion Polymerase Rev3L in the Tolerance of Alkylating Anticancer Drugs
- (2009) W. P. Roos et al. MOLECULAR PHARMACOLOGY
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Mitochondrial membrane permeabilization in neuronal injury
- (2009) Lorenzo Galluzzi et al. NATURE REVIEWS NEUROSCIENCE
- REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy
- (2009) Huibo Wang et al. NEURO-ONCOLOGY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
- (2008) H J Jun et al. BRITISH JOURNAL OF CANCER
- Down-regulation of Mammalian Sterile 20-Like Kinase 1 by Heat Shock Protein 70 Mediates Cisplatin Resistance in Prostate Cancer Cells
- (2008) A. Ren et al. CANCER RESEARCH
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- (2008) Kei-ichi Ozaki et al. CANCER SCIENCE
- Patients with ERCC1-Negative Locally Advanced Esophageal Cancers May Benefit from Preoperative Chemoradiotherapy
- (2008) M. K. Kim et al. CLINICAL CANCER RESEARCH
- Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
- (2008) B. Evers et al. CLINICAL CANCER RESEARCH
- Senescence, Apoptosis or Autophagy?
- (2008) José Miguel Vicencio et al. GERONTOLOGY
- Medical Treatment of Advanced Testicular Cancer
- (2008) Darren R. Feldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
- (2008) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
- (2008) Timothy J. Ley et al. NATURE
- ATR: an essential regulator of genome integrity
- (2008) Karlene A. Cimprich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death
- (2008) N Tajeddine et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search